Suspended OBSERVATIONAL NCT02313116

Computed Optical Margin Assessment for Breast Cancer Surgery, Phase I (Part B)

Sponsor: Diagnostic Photonics, Inc.

Interventions Interferometric Synthetic Aperture Microscopy

Updated 8 times since 2017 Last updated: Jul 16, 2019 Started: Apr 30, 2014 Primary completion: Feb 29, 2020 Completion: Mar 18, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Suspended

This trial was suspended. No reason was provided.

Listed as NCT02313116, this observational or N/A phase trial focuses on Breast Cancer and remains suspended. Sponsored by Diagnostic Photonics, Inc., it has been updated 8 times since 2014, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

Change History

8 versions recorded

Sep 2024 — Present [monthly]

Suspended
Jul 2024 — Sep 2024 [monthly]

Suspended
Jan 2021 — Jul 2024 [monthly]

Suspended
Aug 2019 — Jan 2021 [monthly]

Suspended
Jun 2018 — Aug 2019 [monthly]

Suspended

▶ Show 3 earlier versions

Apr 2018 — Jun 2018 [monthly]

Suspended

Phase: NA → None
Feb 2017 — Apr 2018 [monthly]

Suspended NA
Jan 2017 — Feb 2017 [monthly]

Suspended NA

First recorded

Apr 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Diagnostic Photonics, Inc.

Data source: Diagnostic Photonics, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Baltimore, United States